Home - Products - Others - Other Targets - Thalidomide-O-amido-C6-NH2 hydrochloride

Thalidomide-O-amido-C6-NH2 hydrochloride

CAS No. 2376990-31-5

Thalidomide-O-amido-C6-NH2 hydrochloride ( —— )

Catalog No. M27019 CAS No. 2376990-31-5

Thalidomide-O-amido-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker. It can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 338 Get Quote
10MG 501 Get Quote
25MG 807 Get Quote
50MG 1107 Get Quote
100MG 1485 Get Quote
500MG 2961 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Thalidomide-O-amido-C6-NH2 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Thalidomide-O-amido-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker. It can be used in the synthesis of PROTACs.
  • Description
    Thalidomide-O-amido-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker. It can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    P450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2376990-31-5
  • Formula Weight
    466.9
  • Molecular Formula
    C21H27ClN4O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.NCCCCCCNC(=O)COc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Levron, J.C., et al. Pharmacokinetic study of 2,3-dichloro 4- (2-thienyl keto14C) phenoxyacetic acid (tienilic acid) in animals. European Journal of Drug Metabolism and Pharmacokinetics 2, 107–120 (1977).
molnova catalog
related products
  • Cucurbitacin IIb

    Cucurbitacin IIb is one of the major active compounds in Hemsleyadine tablets which have been used for clinical treatment of bacillary dysentery, enteritis and acute tonsilitis.

  • Hosenkoside K

    Hosenkoside K is a baccharane glycoside isolated from the seeds of impatiens balsamina.

  • Bacopaside X

    Bacopaside X (9.06 μM) showed binding affinity towards the D1 receptor.